Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
Preliminary evidence justifies further trials, but that further work is needed before any new routine procedure is established, as there may be an increased risk of fetal death in pregnancies complicated by severe hypertensionedema-proteinuria syndromes and treated with betamethasone. Expand
Improvement in mortality of very low birthweight infants and the changing pattern of neonatal mortality: The 50‐year experience of one perinatal centre
- M. Battin, D. Knight, C. Kuschel, R. Howie
- Journal of paediatrics and child health
- 12 March 2012
Neonatology is a relatively new sub‐specialty so survival data in the context of advances in neonatal care is reviewed, with a focus on neonatal survival data. Expand
School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone.
The cognitive development of children whose mothers had been included in the first Auckland trials of betamethasone therapy in premature labor were studied and Calculations of statistical power showed that important differences were unlikely to have been missed. Expand
Congenital malformations in the newborn: a survey at the National Women's Hospital, 1964-67.
Cognitive and psychosocial development of 4-year-old children whose mothers were treated antenatally with betamethasone.
It was concluded that betamethasone therapy, under the conditions of the original trial, was not hazardous to cognitive development as measured in this study. Expand
12 – The New Zealand Study of Antepartum Glucocorticoid Treatment
Severe Hypertension Treated with Ganglion-blocking Drugs in a General Hospital
The recent introduction of bretylium tosylate and guanethidine, potent hypotensive agents with a different mode of action, makes the time opportune to survey the effectiveness of ganglion-blocking drugs. Expand
Use of Spironolactone and Hydrochlorothiazide in Treatment of Oedema
A new derivative of spirolactone, spironolactone (SC.9420), which is more potent, has recently been developed (Gantt and Dyniewicz, 1959), and the purpose of this study was to investigate its clinical value. Expand